Femi-ExoRevive
1.500,00 AED – 3.600,00 AEDPrice range: 1.500,00 AED through 3.600,00 AED
Femi-Sensory Enhance
2.000,00 AED
Femi-Growth Matrix
1.500,00 AED – 3.600,00 AEDPrice range: 1.500,00 AED through 3.600,00 AED
Includes:
– 2 ml per Session Targeted cellular growth factor repair therapy.
Get an extra 4% discount when you purchase this product from our mobile app!
Description
Description
Femi-Growth Matrix is an advanced regenerative therapy designed to restore feminine tissue health through targeted cellular growth factors. These powerful bioactive molecules stimulate cell repair, collagen formation, and vascular regeneration — delivering focused healing exactly where it’s needed.
How It Works:
- Concentrated growth factors are applied to targeted intimate tissues.
- These signals activate cellular repair pathways and tissue remodeling.
- The therapy boosts collagen production, improves blood supply, and strengthens tissue structure.
Who Can Benefit:
- Women experiencing tissue laxity or thinning.
- Reduced elasticity and tone.
- Postpartum or hormonal changes.
- Mild urinary discomfort.
- Desire for enhanced feminine wellness.
Benefits:
- Accelerated tissue repair and regeneration.
- Improved firmness, hydration, and elasticity.
- Enhanced comfort and sensitivity.
- Non-surgical and minimally invasive.
- Natural, science-driven rejuvenation.
Reviews (0)
Show only reviews in English (0)
Be the first to review “Femi-Growth Matrix” Cancel reply
SKU:
N/A
Category: Women Health
Related products
-20%
Select options
This product has multiple variants. The options may be chosen on the product page
Femi-Dermal Repair LASER
1.200,00 AED – 2.880,00 AEDPrice range: 1.200,00 AED through 2.880,00 AED-20%
Select options
This product has multiple variants. The options may be chosen on the product page
Femi-Scar Restore
1.200,00 AED – 1.920,00 AEDPrice range: 1.200,00 AED through 1.920,00 AED-20%
Select options
This product has multiple variants. The options may be chosen on the product page




Reviews
There are no reviews yet.